Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
BXMAS1, CD307e, Fc receptor homolog 5, Fc receptor-like protein 5, FcR-like protein 5, FCRH5, Immune receptor translocation-associated protein 2, IRTA2
SDS-PAGE analysis of Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356) confirms that the purity of this antibody is 91.59%.
Immobilized recombinant human IRTA2 protein (His tag) at 2 µg/ml is bound by Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356). EC50 = 0.007032 µg/ml.
Publishing research using Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356)? Please let us know so that we can list the citation on this page.
Alternative products to Cevostamab Biosimilar - Anti-FCRL5 Antibody - Low endotoxin, Azide free (A323356)